Answers are grounded in this paper and cite their sources.
Microfluidic technologies are powerful platforms for biomedical research due to their ability to manipulate small fluid volumes with high precision, enabling applications in diagnostics, cell culture, organ-on-chip systems, and drug delivery. Traditional fabrication approaches, including photolithography and soft lithography, remain limited by complex workflows, specialized infrastructure requirements, and challenges in scaling device production. In response, vat photopolymerization-based (VPP) additive manufacturing techniques, particularly digital light processing (DLP) and masked stereolithography (MSLA), have gained increasing attention as alternative fabrication strategies for microfluidic devices. These technologies enable rapid, layer-by-layer fabrication of enclosed three-dimensional (3D) microarchitectures with improved design flexibility, reduced production complexity, and microscale resolution. Within the literature, distinctions between different VPP printing modalities are rarely explored, and instead the entire category is discussed in generalized terms. This review summarizes the principles specifically underlying DLP- and MSLA-based microfluidic fabrication, with emphasis on fabrication parameters including optical clarity, resolution, channel patency, and surface roughness. Material considerations involving rigid structural resins, hydrogels, elastomeric systems, and dynamic responsive materials are discussed alongside the functional capabilities of these devices, such as flow control, mixing, droplet generation, separation, and sensing. Finally, emerging biomedical applications are examined, including organ-on-chip systems, point-of-care diagnostics, and nanoparticle-based drug delivery platforms. Despite ongoing limitations related to material biocompatibility and fabrication fidelity, continued advances in materials and printing technologies are rapidly expanding the translational potential of 3D-printed microfluidic systems.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: